“Different dose of Gen had no significant effect on the expression of BCL-6 and …, but could inhibit the binding of BCL-6 and NCoR. It is concluded that Gen shows inhibitory effect on BCL-6 positive lymphoma cells, … can be as a adjuvant therapy for combined rituximab with ….”